P551: A PHASE 3, RANDOMIZED, OPEN‐LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF MAGROLIMAB IN COMBINATION WITH AZACITIDINE IN PREVIOUSLY UNTREATED PATIENTS WITH TP53‐MUTANT ACUTE MYELOID LEUKEMIA

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; pp. 450 - 451
Main Authors Daver, N. G., Vyas, P., Chao, M. P., Xing, G., Renard, C., Ramsingh, G., Sallman, D. A., Wei, A. H.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 01.06.2022
Wiley
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000845092.62208.b7